Unichem Labs

• 

  Unichem Labs' Shares Jump Over 15%, After 200% Dividend Announcement

  Unichem Laboratories' shares jumped over 15 per cent early on Monday, leading the BSE gainers chart after the company announced a 200 per cent dividend of Rs 4 per equity share on Friday.

• 

  Torrent Pharma To Buy Unichem Labs India Business For Rs 3,600 Crore

  The deal will be funded by internal accruals and bank borrowing, Torrent Pharma said.

• 

  Unichem Labs Q2 Net Slips 11% At Rs 21 Crore

  Unichem manufactures and markets pharmaceutical formulations in India and several other markets across the world.

• 

  Buy KPIT Technologies, Dr Reddy's Labs; Sell Maruti Suzuki: Market Experts

  Independent market analyst, Rajesh Sharma recommends buying KPIT Technologies for target price of Rs 152-160.

• 

  Unichem Lab Gets US Regulator's Nod For Schizophrenia Tablets

  The approval is for the company's tablets in the strengths of 25 mg, 50 mg, 100 mg, 200 mg, 300 mg and 400 mg, it added.

• 

  Unichem Labs Posts Ten-Fold Jump in Q3 Profit

  Drug firm Unichem Laboratories on Saturday reported a nearly ten-fold jump in standalone net profit at Rs 20.54 crore for the quarter ended December 31, mainly on account of robust sales.

• 

  Unichem Lab Gets US FDA nod for Hypertension Drug

  Unichem Laboratories has received final approval from the US health regulator to market generic Irbesartan tablets, used in treating hypertension, in the American market.

• Unichem Labs Surges Post Q1 Results

  Unichem Labs sales jumped 6.5 per cent to 309.07 crore from Rs 290.09 crore during the first quarter of FY15. However, the net profit came in at Rs 28.78 crore compared to Rs 30.19 crore during the same period last year.

• US regulator gives nod to Unichem Labs for anti-infective drug

  Unichem Laboratories has received approval from the US Food and Drug Administration to sell generic Metronidazole tablets, an anti-infective agent, in the American market.

• US regulator gives nod to Unichem Labs for anti-infective drug

  Unichem Laboratories has received approval from the US Food and Drug Administration to sell generic Metronidazole tablets, an anti-infective agent, in the American market.

• Unichem Lab Q2 net profit up 3% at Rs 36.2 crore

  The company had posted a profit of Rs 35.07 crore in the corresponding quarter of the previous fiscal, Unichem said in a filing to the BSE.

• Unichem Labs Q3 net profit dips 4.45% to Rs 24.46 crore

  The total income of the firm was driven by revenues outside India, Unichem said.

• Unichem Labs earmarks Rs 120 crore for capex activities in FY12

  Unichem Laboratories has earmarked Rs 120 crore for capital expenditure plans in the current financial year, including the establishment of a new SEZ formulations plant and an R&D centre. "Approximately Rs 120 crore would be invested in capex (capital expenditure) in FY'12, of which Rs 40 crore would be spent for the formulations plant at th...

• Unichem Lab jumps 8% in two days

  Unichem Laboratories rose 1.18% to Rs 287 at 10:45 IST on BSE, extending gains for the second consecutive day, after the company's unit Niche Generics got marketing approval for Anastrozloe tablets for a number of markets within the European Union.The company made this announcement during trading hours on Friday, 4 December 2009, when the stock had...

• BSE NOTICE: Unichem Lab's drug gets Europe suitability certificate

  MUMBAI, SEPTEMBER 23: Text of notice on Unichem Laboratories Ltd published on Bombay Stock Exchange's Web site Thursday: Unichem Laboratories Ltd has informed BSE that the Company have been granted Certificate of suitability to European Pharmacopeia (CEP) by European Directorate for the Quality of Mechcines and Healthcare (EDQM) for Alfuzosin Hy...